We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.18%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRVI icon
14126
CALL
Trevi Therapeutics
TRVI
$2.64B
$2.04K ﹤0.01%
1,100
-100
-8% -$226
ZH
14127
PUT
Zhihu
ZH
$279M
$2.03K ﹤0.01%
267
-1,416
-84% -$13.1K
UWMC icon
14128
UWM Holdings
UWMC
$434M
$2.03K ﹤0.01%
413
-35,462
-99% -$156K
BZFDW icon
14129
BuzzFeed Inc Warrant
BZFDW
$643K
$2.02K ﹤0.01%
18,131
-7,900
-30% -$1.29K
PIIIW icon
14130
P3 Health Partners Inc Warrant
PIIIW
$179K
$2.02K ﹤0.01%
+25,186
New +$2.97K
YMAB
14131
PUT
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
+400
New +$1.63K
REK icon
14132
PUT
ProShares Short Real Estate
REK
$11.8M
$2K ﹤0.01%
100
-500
-83% -$9.81K
KBNT
14133
CALL
DELISTED
Kubient, Inc. Common Stock
KBNT
$2K ﹤0.01%
+2,900
New +$2.34K
RMGCW
14134
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$1.99K ﹤0.01%
+13,682
New +$1.81K
DMRA
14135
PUT
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$1.99K ﹤0.01%
+40
New +$2.11K
SQFT icon
14136
PUT
Presidio Property Trust
SQFT
$1.98K ﹤0.01%
+190
New +$2.09K
AAU
14137
CALL
DELISTED
Almaden Minerals Ltd
AAU
$1.98K ﹤0.01%
+10,400
New +$2.29K
GOEVW
14138
DELISTED
Canoo Inc. Warrant
GOEVW
$1.97K ﹤0.01%
+22,483
New +$3.91K
ZEPP
14139
CALL
Zepp Health
ZEPP
$69.7M
$1.97K ﹤0.01%
375
+300
+400% +$2.12K
QQQH
14140
PUT
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$384M
$1.97K ﹤0.01%
50
-750
-94% -$28.7K
LTRN icon
14141
PUT
Lantern Pharma
LTRN
$36.5M
$1.93K ﹤0.01%
400
NMTR
14142
DELISTED
9 Meters Biopharma
NMTR
$1.93K ﹤0.01%
1,388
-151
-10% -$285
PASG icon
14143
CALL
Passage Bio
PASG
$14.1M
$1.92K ﹤0.01%
100
-825
-89% -$22.4K
OSAAW
14144
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$1.91K ﹤0.01%
13,713
-8,928
-39% -$1.12K
IZEA icon
14145
CALL
IZEA Worldwide
IZEA
$61.3M
$1.89K ﹤0.01%
+725
New +$1.87K
GLRE icon
14146
PUT
Greenlight Captial
GLRE
$506M
$1.88K ﹤0.01%
+200
New +$1.89K
SUNL
14147
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$1.88K ﹤0.01%
301
-4,566
-94% -$101K
NEXN
14148
Nexxen International
NEXN
$607M
$1.86K ﹤0.01%
354
-20,528
-98% -$144K
ASLN
14149
CALL
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.86K ﹤0.01%
80
+77
+2,567% +$2.08K
SLDB icon
14150
PUT
Solid Biosciences
SLDB
$900M
$1.85K ﹤0.01%
+390
New +$2.34K

Similar funds

Citadel Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.

  • Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Citadel Advisors opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.